🇺🇸 Torsemide Tablets in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Abdominal Discomfort — 1 report (10%)
2. Amnesia — 1 report (10%)
3. Anaphylactic Shock — 1 report (10%)
4. Cerebrovascular Accident — 1 report (10%)
5. Chills — 1 report (10%)
6. Condition Aggravated — 1 report (10%)
7. Coronary Artery Disease — 1 report (10%)
8. Deep Vein Thrombosis — 1 report (10%)
9. Dehydration — 1 report (10%)
10. Drug Effect Decreased — 1 report (10%)

Source database →

Frequently asked questions

Is Torsemide Tablets approved in United States?

Torsemide Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Torsemide Tablets in United States?

China National Center for Cardiovascular Diseases is the originator. The local marketing authorisation holder may differ — check the official source linked above.